WebNews
Please enter a web search for web results.
NewsWeb
Altitude Labs serves up higher education for biotech founders
12+ min ago (867+ words) Carmen Kivisild presents her company Elnora, an AI agent for lab protocols, at Altitude Labs" Demo Day on April 15. This is Altitude Labs. And today is graduation day, so to speak. Once a year, Altitude hosts Demo Day, giving each…...
Niagen Bioscience Adds Olympia Pharmaceuticals to 503 B Compounding Partner Network for Niagen Plus
2+ hour, 53+ min ago (200+ words) Partnership unlocks Olympia's established clinic network for Niagen Plus, expands pharmaceutical-grade Niagen supply chain, and brings liquid compounded vials to market "We anticipate that Olympia will play an important role in meeting the growing demand for Niagen IV and Niagen…...
Masimo SET" Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study
12+ hour, 28+ min ago (842+ words) Bio Space Masimo SET" Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study NICU Study Adds to the Evidence Demonstrating SET's Accuracy in Challenging Real-World Settings, With No Clinically Significant Differences in Performance…...
Ashvattha Therapeutics Announces Presentations Highlighting Mechanism of Action for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
3+ hour, 25+ min ago (188+ words) Migaldendranib (MGB) is a new class of targeted nanomedicine for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (n AMD) with a novel mechanism of action that normalizes VEGF, IL-6, and IL-1" expression. MGB, delivered via subcutaneous (sub…...
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
18+ hour, 24+ min ago (230+ words) Sample technologies, QIAcuity and QDI deliver solid growth; Quanti FERON sales affected by significantly lower immigration testing demand For Q1 2026, preliminary net sales were $492 million, up 2% on a reported basis and down 1% at constant exchange rates (CER) compared with the outlook…...
Catal Ym Appoints Christian S. Schade as Chairman of the Board of Directors
12+ hour, 56+ min ago (617+ words) Bio Space Catal Ym Appoints Christian S. Schade as Chairman of the Board of Directors MUNICH & SAN FRANCISCO--(BUSINESS WIRE)--Catal Ym today announced the appointment of seasoned biotech executive Christian S. Schade as Chairman of the Board of Directors. With over…...
Zimmer Biomet Announces Chief Financial Officer Transition
13+ hour, 45+ min ago (230+ words) Suketu Upadhyay to Depart; Paul Stellato Named Interim CFO WARSAW, Ind. , April 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced Suketu Upadhyay, Chief Financial Officer and Executive Vice President, Finance, Operations and…...
Poly Pid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting
13+ hour, 40+ min ago (326+ words) Bio Space Poly Pid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting Analysis demonstrates statistically significant reduction in the severity of surgical wound infections, with potential to…...
Veradermics Announces Launch of Public Offering
18+ hour, 14+ min ago (571+ words) Bio Space Veradermics Announces Launch of Public Offering NEW HAVEN, Conn. --(BUSINESS WIRE)--Veradermics, Incorporated (Veradermics) (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, today announced that it has launched a…...
Insulet to Participate in Bof A Securities 2026 Health Care Conference
12+ hour, 28+ min ago (225+ words) Bio Space Insulet to Participate in Bof A Securities 2026 Health Care Conference ACTON, Mass. --(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod" brand of products, today announced that management will present…...